Document management systems for medical writing

Brendan Thorne

Volume 28, Issue 2 - Generics and biosimilars

Document management systems for medical writing

Author: Brendan Thorne

Abstract

Clinical trial data are rightfully protected by robust regulations; given these requirements and increasing demands from clients, a validated and compliant electronic document management system is now a necessity for established medical writing organisations and contract research organisations. Even without this impetus, the improvements in admin istrative function, audit readiness, and team collaboration can justify the investment required.

Download the full article

References

FDA, CFR - Code of Federal Regulations Title 21, Volume 1. Revised: 01 April 2018 [cited 2019 April 26]. Available from: Available from: https://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfcfr/CFRSearch.cfm? CFRPart=11.
Article 47 of European Commission Directive 2001/83/EC. Volume 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. Annex 11: Computerised Systems. [cited 2019 April 26]. Available from: Available from: https://ec.europa.eu/health/sites/health/ files/files/eudralex/vol-4/annex11_01– 2011_en.pdf.
FDA Guidance for Industry Part 11, Electronic Records; Electronic Signatures – Scope and Application. [cited 2019 April 26]. Available from: Available from: https://www.fda.gov/downloads/Regulatory Information/Guidances/ucm125125.pdf.

Volume 28, Issue 2 - Generics and biosimilars

Document management systems for medical writing

Author: Brendan Thorne

Abstract

References

Search

Articles

Links

Editoral Board